Chronic Obstructive Pulmonary Disease
Conditions
Brief summary
Static hyperinflation is frequent in Chronic obstructive pulmonary disease (COPD) , resulting in increased end expiratory lung volume and positive end expiratory pressure (PEEPi) at the end of a normal expiration. Static hyperinflation worsens the work of breathing is increases patient's dyspnea. The application of a continuous positive airway pressure (CPAP) has been shown to improve static hyperinflation and to decrease the work of breathing. Sleep is deteriorated in COPD patients, and causal factors includes static hyperinflation. The purpose of our study is to assess the effect of nocturnal CPAP on sleep quality and functional respiratory parameters.
Detailed description
Chronic obstructive pulmonary disease (COPD) is characterized by an airflow obstruction, inducing a flow limitation. As a consequence, we observe in these patients an increased end expiratory lung volume and a positive end expiratory pressure (PEEPi) at the end of a normal expiration. Patients are breathing at higher pulmonary volumes: this is the concept of static hyperinflation. This worsens the breathing pattern because in this situation, the work of breathing is increased such that dyspnea increases. The application of a continuous positive airway pressure (CPAP) has been shown to improve static hyperinflation and to decrease the work of breathing. Sleep is deteriorated in COPD patients, and causal factors includes static hyperinflation, cough, depression. Moreover, normal physiological changes occuring during sleep in COPD patients are leading to deterioration of gaseous exchanges. The purpose of our study is to assess the effect of nocturnal CPAP on sleep quality and functional respiratory parameters.
Interventions
positive airway pressure given by a medical device through a nasal mask
Sponsors
Study design
Eligibility
Inclusion criteria
* stable chronic obstructive pulmonary disease patients exhibiting a FEV1\<80 %,
Exclusion criteria
* Known sleep apnea syndrome or other sleep disease interfering with sleep quality * Body mass index \> 30 kg/m2 * heart failure * hypnotics intake
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| sleep quality | day 1 | sleep efficiency, total sleep time, sleep architecture measured by polysomnography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| static hyperinflation | day 1 | measure of static hyperinflation by lung function test after the night spent with CPAP |